#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alveolar rhabdomyosarcoma Neoplasm Alpha-1 antitrypsin deficiency Activated PI3 kinase delta syndrome Pulmonary sarcoidosis Cutaneous lupus erythematosus Hypochromic anaemia Anal cancer Scleroderma associated digital ulcer Acute graft versus host disease in skin Myelodysplastic syndrome Cutaneous T-cell lymphoma stage II Osteosarcoma recurrent Rett syndrome Netherton's syndrome More trials…

    Learn about Rare Diseases

    Von Willebrand’s disease – Diagnostics Rett syndrome – Trials in Disease Hereditary motor and sensory neuropathy Advanced systemic mastocytosis – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Basic Information Nephrotic syndrome – Life with Disease Systemic mastocytosis Leiomyosarcoma recurrent – Diagnostics Aicardi-Goutieres syndrome – Diagnostics Phenylketonuria – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pentixather Izorlisib Mesilate Tx200-Tr101 Nefopam AUROCELL-TX DNL593 Gedatolisib Kbp-336 Streptococcus Pneumoniae Iomeprol Cladribine Sodium Phosphate Ly3537982 Naloxegol Oxalate Zopiclone Phenol, Liquefied Omp72 Epcoritamab Posdinemab Ro7589655 More therapies…

    Learn about Your Condition

    Dry mouth Biliary neoplasm Staphylococcal bacteraemia Liposarcoma metastatic Metastasis Extraskeletal ossification Supraventricular tachycardia Cortical dysplasia Propionic acidaemia Pyrexia Post procedural swelling Prostate cancer metastatic Generalised anxiety disorder Malignant neoplasm of choroid Tumour of ampulla of Vater More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Upadacitinib for Patients with Active Psoriatic Arthritis and Axial Spondyloarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Upadacitinib
    Belgium Poland

  • Treatment with Mesenchymal Stromal Cells for Adults with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS-TEN) Affecting More Than 10% of Body Surface

    Recruiting

    1 1 1
    Investigated Diseases:
    • Toxic epidermal necrolysis
    Investigated Drugs:
    • Allogeneic Adipose-Derived Mesenchymal Stromal Cells, Ex-Vivo Expanded
    France

  • Study on Brain Changes in Alzheimer’s Disease Using Flutemetamol (18F) and Fludeoxyglucose (18F) in ALFA Project Participants

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Flutemetamol (18F)
    • Fludeoxyglucose (18F)
    Spain

  • Study on Metabolic Impairment in ALS and TIA Patients Using Hyperpolarized Pyruvate MRI

    Recruiting

    2 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Pyruvic Acid
    Denmark

  • Study on Ovarian Stimulation Using Follitropin Delta and Dydrogesterone for Women Donating Eggs

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dydrogesterone
    • Follitropin Delta
    Belgium

  • Study on Clopidogrel and Dalteparin Sodium for Preventing Blood Clots in Pancreatic Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Clopidogrel
    • Dalteparin Sodium
    Norway
Previous Page
1 … 186 187 188 189 190 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!